Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Pathological significance and prognostic value of surfactant protein D in cancer

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • Contributors:
      Mangogna, Alessandro; Belmonte, Beatrice; Agostinis, Chiara; Ricci, Giuseppe; Gulino, Alessandro; Ferrara, Ine; Zanconati, Fabrizio; Tripodo, Claudio; Romano, Federico; Kishore, Uday; Bulla, Roberta
    • الموضوع:
      2018
    • Collection:
      Università degli studi di Trieste: ArTS (Archivio della ricerca di Trieste)
    • نبذة مختصرة :
      Surfactant protein D (SP-D) is a pattern recognition molecule belonging to the Collectin (collagen-containing C-type lectin) family that has pulmonary as well as extra-pulmonary existence. In the lungs, it is a well-established opsonin that can agglutinate a range of microbes, and enhance their clearance via phagocytosis and super-oxidative burst. It can interfere with allergen–IgE interaction and suppress basophil and mast cell activation. However, it is now becoming evident that SP-D is likely to be an innate immune surveillance molecule against tumor development. SP-D has been shown to induce apoptosis in sensitized eosinophils derived from allergic patients and a leukemic cell line via p53 pathway. Recently, SP-D has been shown to suppress lung cancer progression via interference with the epidermal growth factor signaling. In addition, a truncated form of recombinant human SP-D has been reported to induce apoptosis in pancreatic adenocarcinoma via Fas-mediated pathway in a p53-independent manner. To further establish a correlation between SP-D presence/levels and normal and cancer tissues, we performed a bioinformatics analysis, using Oncomine dataset and the survival analysis platforms Kaplan–Meier plotter, to assess if SP-D can serve as a potential prognostic marker for human lung cancer, in addition to human gastric, breast, and ovarian cancers. We also analyzed immunohistochemically the presence of SP-D in normal and tumor human tissues. We conclude that (1) in the lung, gastric, and breast cancers, there is a lower expression of SP-D than normal tissues; (2) in ovarian cancer, there is a higher expression of SP-D than normal tissue; and (3) in lung cancer, the presence of SP-D could be associated with a favorable prognosis. On the contrary, at non-pulmonary sites such as gastric, breast, and ovarian cancers, the presence of SP-D could be associated with unfavorable prognosis. Correlation between the levels of SP-D and overall survival requires further investigation. Our analysis involves a large number ...
    • File Description:
      ELETTRONICO
    • Relation:
      info:eu-repo/semantics/altIdentifier/pmid/30127783; info:eu-repo/semantics/altIdentifier/wos/WOS:000440804700001; volume:9; issue:AUG; firstpage:1748; lastpage:1759; numberofpages:12; journal:FRONTIERS IN IMMUNOLOGY; http://hdl.handle.net/11368/2928843; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85051131623; https://www.frontiersin.org/articles/10.3389/fimmu.2018.01748/full
    • الرقم المعرف:
      10.3389/fimmu.2018.01748
    • الرقم المعرف:
      10.3389/fimmu.2018.01748/full
    • الدخول الالكتروني :
      http://hdl.handle.net/11368/2928843
      https://doi.org/10.3389/fimmu.2018.01748
      https://www.frontiersin.org/articles/10.3389/fimmu.2018.01748/full
    • Rights:
      info:eu-repo/semantics/openAccess
    • الرقم المعرف:
      edsbas.B222B47F